Posts in tag

liver health


Debbie Rigby rounds up the latest in research news Electronic cigarettes and health outcomes An umbrella and systematic review of the global evidence has concluded that E‐cigarettes can be harmful …

As the COVID-19 crisis in NSW continues, there’s been plenty happening in the pharmacy sector this week More and more pharmacies were added to the list of COVID-19 exposure sites …

A supplier of unapproved sports supplements has been told to pay $11 million, as the TGA points out their potential to damage health The Federal Court of Australia has ordered …

Debbie Rigby takes a look at the latest in research news Inhaled budesonide in the treatment of early COVID-19 (STOIC) A randomised controlled trial (Steroids in COVID-19; STOIC) of inhaled …

The TGA is investigating the safety of Valerian following a small number of reports of liver injury Noting common uses for Valeriana officinalis – such as to help manage nervousness, …

With many of Australia’s pharmacists descending on Sydney to attend the PSA19 conference, it’s been a very busy week in the world of pharmacy… At the conference, Health Minister Greg …

What impact can pharmacists have on the uptake of DAAs? asks Carlene McMaugh Hepatitis C is now in a unique category of conditions where we have a medication that can …

Direct-acting antivirals are associated with reduced risk of mortality and liver cancer, according to results from the first prospective, longitudinal study investigating their use in treating chronic hepatitis C The …

Deaths from hepatitis C have dropped by a fifth, highlighting the importance of new treatments and their affordability New Kirby Institute data presented at the Australasian Viral Hepatitis Conference in …

The number of Australians receiving breakthrough antiviral therapy to cure hepatitis C has sharply declined This has prompted appeals for more Australians living with the virus to come forward to …

Guild Learning and Development is partnering with Gilead Sciences in an online course The course is titled Management of Hepatitis C and the role of pharmacy. Hepatitis C (HCV), a …

Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …